Limiting effects of a tick kunitz protease inhibitor on rickettsial infection
蜱库尼兹蛋白酶抑制剂对立克次体感染的限制作用
基本信息
- 批准号:7741122
- 负责人:
- 金额:$ 16.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAffectAffinityAnimalsAntibodiesArthropodsBindingBiological AssayBiologyBloodBlood group antibody DBovine AnaplasmosisCell Surface ProteinsCell surfaceCellsCo-ImmunoprecipitationsDataDermacentorDevelopmentDiseaseDisseminated Malignant NeoplasmEndosomesEquilibriumEscherichia coliFabaceaeFeverFutureGoalsGrowthHost DefenseHumanIn VitroInfectionInstructionIxodidaeKnowledgeLaboratoriesLearningLigandsLyme DiseaseMediatingMembrane ProteinsMethodsMicrobeMicrococcus luteusMidgutMolecularNational Institute of Allergy and Infectious DiseaseOrganismPAWR proteinPeptide HydrolasesPhysiologicalPlant RootsPrincipal InvestigatorPropertyProtease InhibitorProteinsPublic HealthPublicationsRNA InterferenceRadarRecombinantsResearchResearch InfrastructureRhizobiumRickettsiaRocky Mountain Spotted FeverRoleSerumSideSpecificitySpottingsSurfaceSymbiosisTestingTick ControlTicksVaccinesVector-transmitted infectious diseasebasecancer celldefense responsedesigndisease transmissionfightingin vivointerestmedical specialtiesmeetingsmethod developmentmicrobialmicroorganismpathogenpreventprotein protein interactionpublic educationresearch studyresponsesuccesstherapy designtransmission processtrendvectorvector transmission
项目摘要
DESCRIPTION (provided by applicant): Successful tick-rickettsiae symbioses become stable as each organism's struggle for survival levels to a state of tolerance. Research demonstrates that Rickettsia montanensis elicits a defense response from the hard tick, Dermacentor variabilis. To establish a niche within a tick, rickettsiae must evade that response. Defining the biology that drives the transmission of vector-borne diseases has implications for public health. For instance, deciphering the underpinnings of the balance between tick defense and rickettsial invasion forms the basis of research that aims to interrupt transmission of vector-borne diseases. NIAID identified disruption of disease transmission by arthropods as a major research focus in its publication "Planning for the 21st Century." My long-term goal is to understand how vector-borne pathogens colonize arthropods in the presence of an active host defense response. Our preliminary studies support our central hypothesis that D. variabilis-Kunitz-type protease inhibitor (Dv-KPI) limits rickettsial infection of the tick midgut by inactivating a rickettsial colonization factor. First, antibody-mediated neutralization of Dv-KPI results in increased rickettsial colonization in vitro. Second, RNAi-mediated knockdown of Dv-KPI in ticks results in an increase in R. montanensis burden in the midgut. Third, a bacterial affinity pulldown assay shows that Dv-KPI associates with R. montanensis. Fourth, a preliminary pulldown study suggests that Dv-KPI precipitates a rickettsial ligand. To address my long-term goal, NIAID's research focus and the central hypothesis, two aims are proposed. Specific Aim I - To determine if Dv-KPI limits R. montanensis entry and transmigration of the D. variabilis midgut. By suppressing Dv-KPI function in the tick, we will test further the effect that Dv-KPI has on rickettsial colonization and transmigration though the tick midgut. We will also investigate if entry is limited at the host cell perimeter or through endosomal escape. Specific Aim II - To identify the rickettsial ligand(s) for Dv-KPI. Using pulldown and Co-IP methods, we will identify and confirm the identity of the interacting rickettsial ligand(s). Completion of these aims will help to define the molecular attributes of the tick-rickettsiae interaction, which is central to the natural transmission cycle that leads to human infection.
RELEVANCE (See instructions): Dv-KPI's observed affect on rickettsial growth forms the basis of our studies to investigate the factors that contribute to a state of tolerance between the tick and rickettsiae. Exploiting this knowledge to develop methods to interrupt tick transmission of pathogenic rickettsiae to humans addresses NIAID's research focus to disrupt disease transmission by arthropods.
描述(由申请人提供):成功的蜱-立克次体共生体变得稳定,因为每个生物体的生存水平的斗争,以一个国家的宽容。研究表明,蒙大拿立克次体是硬蜱Dermacentor variabilis的防御反应。为了在蜱虫体内建立一个生态位,立克次体必须避开这种反应。确定推动病媒传播疾病传播的生物学因素对公共卫生具有重要意义。例如,破译蜱虫防御和立克次体入侵之间平衡的基础构成了旨在中断媒介传播疾病传播的研究基础。NIAID在其出版物《21世纪规划》中确定了节肢动物破坏疾病传播的主要研究重点。“我的长期目标是了解媒介传播的病原体如何在存在主动宿主防御反应的情况下定殖节肢动物。我们的初步研究支持我们的中心假设,D。变异库尼茨型蛋白酶抑制剂(Dv-KPI)通过灭活立克次体定殖因子来限制蜱中肠的立克次体感染。首先,抗体介导的Dv-KPI中和导致体外立克次体定殖增加。其次,RNAi介导的蜱中Dv-KPI的敲低导致R.中肠中的Montanensis负担。第三,细菌亲和下拉试验表明Dv-KPI与R.蒙大拿人。第四,初步的下拉研究表明,Dv-KPI沉淀立克次体配体。为了解决我的长期目标,NIAID的研究重点和中心假设,提出了两个目标。具体目标I -确定Dv-KPI是否限制R。montanensis的进入和迁移。变异中肠通过抑制蜱中的Dv-KPI功能,我们将进一步测试Dv-KPI对立克次体通过蜱中肠的定殖和迁移的影响。我们还将研究进入是否局限于宿主细胞周边或通过内体逃逸。具体目标II -鉴定Dv-KPI的立克次体配体。使用下拉和Co-IP方法,我们将识别和确认相互作用的立克次体配体的身份。这些目标的完成将有助于确定蜱-立克次体相互作用的分子属性,这是导致人类感染的自然传播周期的核心。
相关性(参见说明):Dv-KPI对立克次体生长的观察影响构成了我们研究的基础,以调查促成蜱和立克次体之间耐受状态的因素。利用这些知识来开发中断蜱传播致病性立克次体给人类的方法,解决了NIAID的研究重点,以破坏节肢动物的疾病传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHANE M CERAUL其他文献
SHANE M CERAUL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Fellowship Programs